AHF’s Department of Health and Human Services AIDS Protest Targets Approval of Gilead Sciences, Inc.’s Prevention Pill

Published: Jan 26, 2012

WASHINGTON--(BUSINESS WIRE)--Advocates from AIDS Healthcare Foundation (AHF) will host a protest at the headquarters of the Department of Health and Human Services (HHS) which houses an office of the Food and Drug Administration (FDA) on Thursday, January 26th at 10:00am Eastern Time over the FDA’s refusal to release documents regarding its contact and correspondence with Gilead Sciences about the potential FDA approval of Gilead’s blockbuster AIDS drug Truvada for use as a form of HIV prevention in uninfected individuals. The FDA is now considering approval of this drug despite numerous failed clinical trials, a move which many AIDS providers and advocates feel is unwarranted based on the studies and would set a dangerous precedent.

Back to news